Cambridge, United Kingdom

Thomas Andrew Moss

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignee: Astrazeneca Ab. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Andrew Moss. Retrieved from https://idiyas.com/inventor/thomas-andrew-moss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 100.0


 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Inventor Thomas Andrew Moss

Introduction: Thomas Andrew Moss is a renowned inventor based in Cambridge, United Kingdom, known for his groundbreaking contributions to various fields of technology.

Latest Patents: Thomas Andrew Moss holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in the industry, Thomas Andrew Moss has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized their respective fields.

Collaborations: Throughout his career, Thomas Andrew Moss has collaborated with top companies, banks, and innovative startups to bring his inventions to the market, solidifying his reputation as a visionary inventor.

Conclusion: Thomas Andrew Moss continues to push the boundaries of innovation, with his passion for creating impactful solutions that shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…